Last10K.com

Cme Group Inc. (CME) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, December 31, 2014

Cme Group Inc.

CIK: 1156375 Ticker: CME





Exhibit 99.1
 
 
 
Media contact
Investor contact
 
Anita Liskey, 312.466.4613
John Peschier, 312.930.8491
 
William Parke, 312.930.3467
CME-G
 
news@cmegroup.com
 
 
www.cmegroup.mediaroom.com
 

FOR IMMEDIATE RELEASE
CME Group Inc. Reports Fourth-Quarter 2014 and Full-Year Financial Results
Fourth-quarter revenues rose 22 percent and represented second highest quarterly revenue
Fourth-quarter diluted earnings per share increased more than 50 percent
Annual overall average daily volume reached a record 13.7 million contracts in 2014, along with annual records in interest rates and options
CHICAGO, February 5, 2015 — CME Group Inc. (NASDAQ: CME) today reported revenues of
$841 million and operating income of $472 million for the fourth quarter of 2014. Net income attributable to CME Group was $306 million and diluted earnings per share were $0.91. Excluding the items noted in the reconciliation, adjusted earnings per share would have been $0.951.
“During the fourth quarter, we saw a pickup in volatility that helped drive broad-based growth across all our major product offerings,” said CME Group Executive Chairman and President Terry Duffy.  “Average daily volume reached nearly 15 million contracts, up more than 30 percent and representing the second highest quarterly volume in our history.  This strong performance also reflects the success of our investments to spur organic growth by attracting trading from customers outside the United States.  In addition, we have made significant progress with our OTC initiatives, which continue to drive more activity in our core products.  As a result, our revenue during the quarter was up more than 20 percent, and earnings per share rose more than 50 percent.”
“We saw significant growth in every product area during the fourth quarter, ranging from 14 percent in metals to 41 percent in interest rates,” said CME Group Chief Executive Officer Phupinder Gill.  “Total options rose 38 percent and futures grew 29 percent compared with the same period last year, while electronic options increased more than 50 percent.  International volumes also grew by nearly 50 percent, reaching a record 3 million contracts per day in the fourth quarter.  We also reached our highest level of open interest ever and broke the record for highest daily volume.  Further, we restructured the business during the quarter, positioning ourselves to generate higher margins and earnings going forward.”

1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to Non-GAAP Measures chart at the end of the financial statements.
- more -



The following information was filed by Cme Group Inc. (CME) on Thursday, February 5, 2015 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Cme Group Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cme Group Inc..

Continue

Assess how Cme Group Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cme Group Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Dei Statement
Consolidated Balance Sheets
Consolidated Balance Sheets Balance Sheet Parenthicals
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Income
Consolidated Statements Of Shareholders' Equity
Consolidated Statements Of Shareholders' Equity Equity Statement Parentheticals
Accumulated Other Comprehensive Income (loss)
Accumulated Other Comprehensive Income (loss) (schedule Of Accumulated Other Comprehensive Income) (details)
Accumulated Other Comprehensive Income (loss) (tables)
Capital Stock
Capital Stock (capital Stock) (details)
Capital Stock (narrative) (details)
Capital Stock (tables)
Commitments
Commitments (narrative) (details)
Commitments (non-cancelable Operating Leases And Contractual Obligations) (details)
Commitments (tables)
Contingencies
Contingencies (details)
Debt
Debt (fair Value Of Fixed Rate Notes By Maturity Date) (details)
Debt (long-term Debt Maturities At Par Value) (details)
Debt (narrative) (details)
Debt (schedule Of Short-term And Long-term Debt) (details)
Debt (tables)
Derivative Instruments
Derivative Instruments (effect Of Derivative Instruments On The Statements Of Income And Shareholders' Equity) (details)
Derivative Instruments (narrative) (details)
Derivative Instruments (tables)
Derivative Instruments Fair Value Of Derivatives By Balance Sheet Location (details)
Earnings Per Share
Earnings Per Share (basic And Diluted Earnings Per Share) (details)
Earnings Per Share (tables)
Employee Benefit Plans
Employee Benefit Plans (accumulated Other Comprehensive Income (loss), Of The Prior Service Costs And Actuarial Losses) (details)
Employee Benefit Plans (anticipated Benefit Payments From The Plan In Future Years) (details)
Employee Benefit Plans (asset Allocation For The Plan) (details)
Employee Benefit Plans (change In Plan Assets) (details)
Employee Benefit Plans (components Of Net Pension Expense) (details)
Employee Benefit Plans (fair Value Of Plan Assets) (details)
Employee Benefit Plans (narrative) (details)
Employee Benefit Plans (summary Of The Change In Projected Benefit Obligation) (details)
Employee Benefit Plans (tables)
Employee Benefit Plans (target Allocation Percentages) (details)
Fair Value Measurements
Fair Value Measurements (financial Instruments Measured At Fair Value On A Recurring Basis) (details)
Fair Value Measurements (narrative) (details)
Fair Value Measurements (reconciliation Using Significant Unobservable Inputs) (details)
Fair Value Measurements (tables)
Guarantees
Guarantees (details)
Income Taxes
Income Taxes (deferred Tax Assets (liabilities) ) (details)
Income Taxes (federal Income Tax Rate) (details)
Income Taxes (income Tax Provision) (details)
Income Taxes (reconciliation Of Unrecognized Tax Benefits) (details)
Income Taxes (summary Of Unrecognized Tax Benefits) (details)
Income Taxes (tables)
Income Taxes Income Taxes (narrative) (details)
Intangible Assets And Goodwill
Intangible Assets And Goodwill (components Of Intangible Assets) (details)
Intangible Assets And Goodwill (future Estimated Amortization Expense) (details)
Intangible Assets And Goodwill (goodwill Activity) (details)
Intangible Assets And Goodwill (narrative) (details)
Intangible Assets And Goodwill (tables)
Intangible Assets And Goodwill Intangible Assets And Goodwill (useful Lives Of Intangible Assets) (details)
Long-term Investments
Long-term Investments (details)
Marketable Securities
Marketable Securities (amortized Cost And Fair Value Of Marketable Securities) (details)
Marketable Securities (available-for-sale Securities) (details)
Marketable Securities (narrative) (details)
Marketable Securities (tables)
Organization And Business
Organization And Business (details)
Performance Bonds And Guaranty Fund Contributions
Performance Bonds And Guaranty Fund Contributions (cash And Securities Held As Performance Bonds And Guaranty Fund Contributions At Fair Value) (details)
Performance Bonds And Guaranty Fund Contributions (narrative) (details)
Performance Bonds And Guaranty Fund Contributions (performance Bond Deposits And Security Deposits) (details)
Performance Bonds And Guaranty Fund Contributions (tables)
Property
Property (details)
Property (tables)
Quarterly Information (unaudited)
Quarterly Information (unaudited) (details)
Quarterly Information (unaudited) (tables)
Redeemable Non-controlling Interest
Redeemable Non-controlling Interest (details)
Redeemable Non-controlling Interest (tables)
Schedule Ii—valuation And Qualifying Accounts
Schedule Ii—valuation And Qualifying Accounts Schedule Ii—valuation And Qualifying Accounts (details)
Stock-based Payments
Stock-based Payments (compensation Expense And Income Tax Benefit Recognized) (details)
Stock-based Payments (narrative) (details)
Stock-based Payments (restricted Stock Activity) (details)
Stock-based Payments (stock Option Activity) (details)
Stock-based Payments (tables)
Subsequent Events
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (narrative) (details)
Summary Of Significant Accounting Policies (policy)
Ticker: CME
CIK: 1156375
Form Type: 10-K Annual Report
Accession Number: 0001156375-15-000014
Submitted to the SEC: Thu Feb 26 2015 5:22:18 PM EST
Accepted by the SEC: Thu Feb 26 2015
Period: Wednesday, December 31, 2014
Industry: Security And Commodity Brokers Dealers Exchanges And Services

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/cme/0001156375-15-000014.htm